Radiosynthesis of (R,S)-[


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
06 05 2019
Historique:
received: 10 01 2019
revised: 26 02 2019
pubmed: 23 3 2019
medline: 18 2 2020
entrez: 23 3 2019
Statut: ppublish

Résumé

Translocator protein (TSPO) is a biomarker of neuroinflammation, which is a hallmark of many neurodegenerative diseases and has been exploited as a positron emission tomography (PET) target. Carbon-11-labelled PK11195 remains the most applied agent for imaging TSPO, despite its short-lived isotope and low brain permeability. Second-generation radiotracers show variance in affinity amongst subjects (low-, mixed-, and high-affinity binders) caused by the genetic polymorphism (rs6971) of the TSPO gene. To overcome these limitations, a new structural scaffold was explored based on the TSPO pharmacophore, and the analogue with a low-affinity binder/high-affinity binder (LAB/HAB) ratio similar (1.2 vs. 1.3) to that of (R)-[

Identifiants

pubmed: 30900397
doi: 10.1002/cmdc.201900023
pmc: PMC6563049
doi:

Substances chimiques

Fluorine Radioisotopes 0
Radiopharmaceuticals 0
Receptors, GABA 0
TSPO protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

982-993

Subventions

Organisme : Medical Research Council
ID : MR/K02308X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : RG70550
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : RG46503
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_16040
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.

Références

Nat Rev Drug Discov. 2010 Dec;9(12):971-88
pubmed: 21119734
Biochem Soc Trans. 2015 Aug;43(4):586-92
pubmed: 26551697
Technol Cancer Res Treat. 2006 Aug;5(4):337-41
pubmed: 16866564
Contrast Media Mol Imaging. 2017 Sep 25;2017:6592139
pubmed: 29114179
Bioorg Med Chem Lett. 2012 Feb 1;22(3):1308-13
pubmed: 22244939
J Org Chem. 2002 Apr 5;67(7):2375-7
pubmed: 11925260
J Cereb Blood Flow Metab. 2012 Jul;32(7):1393-415
pubmed: 22549622
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1423-1431
pubmed: 29523925
J Nucl Med. 2018 Aug;59(8):1260-1266
pubmed: 29348317
J Nucl Med. 2016 Feb;57(2):165-8
pubmed: 26697963
J Nucl Med. 2016 Nov;57(11):1753-1759
pubmed: 27261523
Angew Chem Int Ed Engl. 2005 Feb 18;44(9):1378-82
pubmed: 15674985
Medchemcomm. 2016 Nov 15;8(1):202-210
pubmed: 30108706
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2201-2210
pubmed: 27349244
ChemMedChem. 2019 May 6;14(9):982-993
pubmed: 30900397
Bioconjug Chem. 2013 Sep 18;24(9):1415-28
pubmed: 23837837
Life Sci. 1983 Aug 1;33(5):449-57
pubmed: 6308375
J Org Chem. 2011 May 20;76(10):4168-72
pubmed: 21491889
Bioorg Med Chem. 2004 Jul 1;12(13):3569-80
pubmed: 15186841

Auteurs

Luxi Qiao (L)

Molecular Imaging Chemical Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Biomedical Campus, Cambridge, CB2 0SZ, UK.

Emily Fisher (E)

Molecular Imaging Chemical Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Biomedical Campus, Cambridge, CB2 0SZ, UK.

Lindsay McMurray (L)

Molecular Imaging Chemical Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Biomedical Campus, Cambridge, CB2 0SZ, UK.

Selena Milicevic Sephton (S)

Molecular Imaging Chemical Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Biomedical Campus, Cambridge, CB2 0SZ, UK.

Matthew Hird (M)

Molecular Imaging Chemical Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Biomedical Campus, Cambridge, CB2 0SZ, UK.

Nisha Kuzhuppilly-Ramakrishnan (N)

Molecular Imaging Chemical Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Biomedical Campus, Cambridge, CB2 0SZ, UK.

David J Williamson (DJ)

Molecular Imaging Chemical Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Biomedical Campus, Cambridge, CB2 0SZ, UK.

Xiouyun Zhou (X)

Molecular Imaging Chemical Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Biomedical Campus, Cambridge, CB2 0SZ, UK.

Eryn Werry (E)

School of Chemistry, The University of Sydney, Building F11, Eastern Avenue, Sydney, NSW, 2006, Australia.

Michael Kassiou (M)

School of Chemistry, The University of Sydney, Building F11, Eastern Avenue, Sydney, NSW, 2006, Australia.

Saijinder Luthra (S)

GE Healthcare, Amersham, HP7 9LL, UK.

William Trigg (W)

GE Healthcare, Amersham, HP7 9LL, UK.

Franklin I Aigbirhio (FI)

Molecular Imaging Chemical Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Biomedical Campus, Cambridge, CB2 0SZ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH